Do data from a large prospective naturalistic study (N=1014, MDD) support the 
new FDA recommendation concerning antidepressants suicidality risk?

Seemüller, F.; Riedel, M.; Mayr, A.; Mundt, C.; Holsboer, F.; Marneros, A.; Laux, G.; Bender, W.; Adli, W.; Heuser, I.; Zeiler, J.; Gaebel, W.; Jäger, M.; Möller, H. J.; Henkel, V.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Do data from a large prospective naturalistic study (N=1014, MDD) support the new FDA recommendation concerning antidepressants suicidality risk?

MPS-Authors

/persons/resource/persons80372

Holsboer, F.
Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Seemüller, F., Riedel, M., Mayr, A., Mundt, C., Holsboer, F., Marneros, A., et al. (2007). Do data from a large prospective naturalistic study (N=1014, MDD) support the new FDA recommendation concerning antidepressants suicidality risk? Pharmacopsychiatry, 40(5), 207-207.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-96AC-8

Abstract

There is no abstract available